
NASDAQ:GEHC
3 expert ratings on GE HealthCare Technologies Inc (GEHC) in the last 12 months: 1 Buy, 0 Hold, 2 Sell. Latest rating: DON'T BUY by Gordon Reid on Oct 21, 2026.
GE's split into 3 was designed to create a lot of value for shareholders. All 3 are different sizes and have different growth profiles. Doesn't own any, and none appeal to him.
GEHC is low-multiple, but weak growth profile. Likely to be an acquisition target down the road.
The other 2 are in really hot sectors right now, in light of geopolitical tensions. Backlogs and estimates of future growth have gone up dramatically. Valuations are rich.
They split the company into 3 to get out of a troubled period. GE Verona has done very well, for instance, which is tied to data centre building. GE Healthcare has done well, but faces some headwinds. AI could make their equipment more efficient, so that's an opportunity. Would I keep all three companies? Each has its virtues, but Verona is very expensive so he'd pass. Would keep the other two. He likes the aerospace business and Healthcare is well-priced.
GE HealthCare Technologies Inc is a American stock, trading under the symbol GEHC (previously GEHC-Q on Stockchase) on the NASDAQ (GEHC). It is usually referred to as NASDAQ:GEHC or GEHC
3 expert ratings on GE HealthCare Technologies Inc (GEHC) in the last 12 months: 1 Buy, 0 Hold, 2 Sell. Latest rating: DON'T BUY by Gordon Reid on Oct 21, 2026. Read the latest stock experts' ratings for GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for GE HealthCare Technologies Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc is followed by 30 investors on Stockchase and is a trending stock that is worth watching.
On 2026-11-03, GE HealthCare Technologies Inc (GEHC) stock closed at a price of $80.45.
On the surface, you'd think it has great promise. He's neutral. Price is not particularly attractive. Doesn't stand apart compared to peers.
At this point, GEV is the one he wants to do more homework on.